Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,730.00
Bid: 1,733.00
Ask: 1,733.50
Change: -16.50 (-0.94%)
Spread: 0.50 (0.029%)
Open: 1,748.50
High: 1,752.50
Low: 1,730.00
Prev. Close: 1,746.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: SocGen Downgrades Rolls-Royce To Sell

Mon, 16th Jun 2014 09:05

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BARCLAYS RAISES RSA TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 538 (102) PENCE
----------
SOCGEN CUTS ROLLS-ROYCE TO 'SELL' ('HOLD') - TARGET 950 (1070) PENCE
----------
SOCGEN RAISES GLAXOSMITHKLINE PRICE TARGET TO 2100 (2075) PENCE - 'BUY'
----------
HSBC RAISES BG GROUP PRICE TARGET TO 1425 (1260) PENCE - 'OVERWEIGHT'
----------
EXANE RAISES RECKITT BENCKISER PRICE TARGET TO 4900 (4500) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS BHP BILLITON PRICE TARGET TO 1850 (2000) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS RIO TINTO PRICE TARGET TO 3800 (4070) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES WEIR GROUP PRICE TARGET TO 2540 (2390) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
GOLDMAN RAISES HISCOX PRICE TARGET TO 607 (606,74) PENCE - 'SELL'
----------
HSBC RAISES PARAGON GROUP PRICE TARGET TO 380 (335) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES DEBENHAMS TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TP 73 (64) PENCE
----------
CREDIT SUISSE CUTS FENNER PRICE TARGET TO 405 (490) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES HALMA PRICE TARGET TO 665 (620) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES LAIRD PRICE TARGET TO 270 (215) PENCE - 'UNDERPERFORM'
----------
CREDIT SUISSE RAISES MORGAN ADVANCED MATERIALS TP TO 310 (270) PENCE - 'UNDERPEFORM'
----------
CREDIT SUISSE RAISES ROTORK PRICE TARGET TO 2600 (2450) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES SENIOR PLC PRICE TARGET TO 335 (315) PENCE - 'OUTPERFORM'
----------
CANACCORD CUTS IG GROUP PRICE TARGET TO 659 (711) PENCE - 'BUY'
----------
NUMIS CUTS CRODA PRICE TARGET TO 2554 (2575) PENCE - 'HOLD'
----------
CANACCORD CUTS IG GROUP PRICE TARGET TO 659 (711) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS SHANKS GROUP PRICE TARGET TO 119 (122) PENCE - 'NEUTRAL'
----------
LIBERUM INITIATES NCC GROUP WITH 'BUY' - TARGET 220 PENCE
----------
Investec Cuts Majestic Wine To Add from Buy, PT 460p
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
Today 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
Today 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
Today 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.